Which antiretroviral with rifampin? - Trip Gulick, MD/ Frank Maldarelli, MD

https://is1-ssl.mzstatic.com/image/thumb/Podcasts211/v4/13/5d/f5/135df56a-9b63-ffad-9b95-f23279ec100b/mza_8001191650329673636.jpg/600x600bb.jpg

IDBR Infectious Disease Board Review

John Bennett, MD / Henry Masur, MD

22 episodes

6 days ago

The Infectious Disease Board Review (IDBR) Course is designed to help physicians prepare for the American Board of Internal Medicine (ABIM) Infectious Disease certification/recertification exam. This comprehensive review features exam-focused lectures presented by the Nation’s leading infectious disease experts, case-based reviews, online practice exams featuring over 500 ABIM-style and photo-based questions, and additional study guides and primers. https://www.idbrcourse.org/

Medicine

Health & Fitness

RSS

All content for IDBR Infectious Disease Board Review is the property of John Bennett, MD / Henry Masur, MD and is served directly from their servers with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.

Medicine

Health & Fitness

https://d3t3ozftmdmh3i.cloudfront.net/staging/podcast_uploaded_nologo/40768357/40768357-1715876268107-be39cae4504ee.jpg

Which antiretroviral with rifampin? - Trip Gulick, MD/ Frank Maldarelli, MD

IDBR Infectious Disease Board Review

3 minutes 1 second

1 year ago

Which antiretroviral with rifampin? - Trip Gulick, MD/ Frank Maldarelli, MD

A 29-year-old man living with HIV on tenofovir alafenamide (TAF)/emtricitabine + dolutegravir (CD4 298, HIV RNA <20 cps/ml) develops pulmonary TB.

The plan is to start empiric INH, RIF, PZA, and ETH pending mycobacterial susceptibilities.

How do you manage his ART regimen?

A. Continue current regimen

B. Change dolutegravir to darunavir/ritonavir

C. Change dolutegravir to elvitegravir

D. Double the dose of dolutegravir